Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6655)
All Articles published online
|
Publishing Process of This Article
|
Sep 7, 2017 (publication date) through Nov 10, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Matsui D, Omstead AN, Kosovec JE, Komatsu Y, Lloyd EJ, Raphael H, Kelly RJ, Zaidi AH, Jobe BA. High yield reproducible rat model recapitulating human Barrett’s carcinogenesis. World J Gastroenterol 2017; 23(33): 6077-6087 [PMID: 28970723 DOI: 10.3748/wjg.v23.i33.6077] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i33/6077.htm |
| Number | Citing Articles |
| 1 |
Juliann E. Kosovec, Ali H. Zaidi, Ashten N. Omstead, Daisuke Matsui, Mark J. Biedka, Erin J. Cox, Patrick T. Campbell, Robert W.W. Biederman, Ronan J. Kelly, Blair A. Jobe. CDK4/6 dual inhibitor abemaciclib demonstrates compelling preclinical activity against esophageal adenocarcinoma: a novel therapeutic option for a deadly disease. Oncotarget 2017; 8(59): 100421 doi: 10.18632/oncotarget.22244
|
| 2 |
Steffen Rickelt, Azfar Neyaz, Charlene Condon, Charles A. Whittaker, Ali H. Zaidi, Martin S. Taylor, Genevieve Abbruzzese, Anthony R. Mattia, Lawrence Zukerberg, Stuti G. Shroff, Omer H. Yilmaz, Osman Yilmaz, Elizabeth Y. Wu, Won-Tak Choi, Blair A. Jobe, Robert D. Odze, Deepa T. Patil, Vikram Deshpande, Richard O. Hynes. Agrin Loss in Barrett's Esophagus-Related Neoplasia and Its Utility as a Diagnostic and Predictive Biomarker. Clinical Cancer Research 2022; 28(6): 1167 doi: 10.1158/1078-0432.CCR-21-2822
|
| 3 |
Ashten N Omstead, Michael Paskewicz, Anastasia Gorbunova, Ping Zheng, Madison S Salvitti, Rubab Mansoor, Payton Reed, Sydne Ballengee, Patrick L Wagner, Blair A Jobe, Ronan J Kelly, Ali H Zaidi. CSF-1R inhibitor, pexidartinib, sensitizes esophageal adenocarcinoma to PD-1 immune checkpoint blockade in a rat model. Carcinogenesis 2022; 43(9): 842 doi: 10.1093/carcin/bgac043
|
| 4 |
Ksenia Maslenkina, Liudmila Mikhaleva, Maxim Naumenko, Rositsa Vandysheva, Michail Gushchin, Dmitri Atiakshin, Igor Buchwalow, Markus Tiemann. Signaling Pathways in the Pathogenesis of Barrett’s Esophagus and Esophageal Adenocarcinoma. International Journal of Molecular Sciences 2023; 24(11): 9304 doi: 10.3390/ijms24119304
|
| 5 |
Wytske M Westra, Danielle Straub, Francesca Milano, Navtej S Buttar, Kenneth K Wang, Kausilia K Krishnadath. Inhibition of the BMP pathway prevents development of Barrett’s-associated adenocarcinoma in a surgical rat model. Diseases of the Esophagus 2022; 35(5) doi: 10.1093/dote/doab072
|
| 6 |
Ryan Sweeney, Ashten N Omstead, John T Fitzpatrick, Ping Zheng, Anastasia Gorbunova, Erin E Grayhack, Arul Goel, Alisha F Khan, Juliann E Kosovec, Patrick L Wagner, Blair A Jobe, Ronan J Kelly, Ali H Zaidi. Sitravatinib combined with PD-1 blockade enhances cytotoxic T-cell infiltration by M2 to M1 tumor macrophage repolarization in esophageal adenocarcinoma. Carcinogenesis 2024; 45(4): 210 doi: 10.1093/carcin/bgad087
|
| 7 |
Omar Martinez-Uribe, Thomas C. Becker, Katherine S. Garman. Promises and Limitations of Current Models for Understanding Barrett’s Esophagus and Esophageal Adenocarcinoma. Cellular and Molecular Gastroenterology and Hepatology 2024; 17(6): 1025 doi: 10.1016/j.jcmgh.2024.01.017
|
| 8 |
Jolanta Majka, Mateusz Wierdak, Aleksandra Szlachcic, Marcin Magierowski, Aneta Targosz, Katarzyna Urbanczyk, Gracjana Krzysiek-Maczka, Agata Ptak-Belowska, Dominik Bakalarz, Katarzyna Magierowska, Anna Chmura, Tomasz Brzozowski. Interaction of epidermal growth factor with COX-2 products and peroxisome proliferator-activated receptor-γ system in experimental rat Barrett’s esophagus. American Journal of Physiology-Gastrointestinal and Liver Physiology 2020; 318(3): G375 doi: 10.1152/ajpgi.00410.2018
|